Advisor Group
CTSO icon

Advisor Group’s Cytosorbents Corp CTSO Stock Holding History

Advisor Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$122K Sell
1,584
-60
-4% -$5.24K ﹤0.01% 2783
2019
Q3 		$165K Sell
1,644
-15
-0.9% -$1.74K ﹤0.01% 2461
2019
Q2 		$219K Buy
1,659
+227
+16% +$31.2K ﹤0.01% 2231
2019
Q1 		$217K Buy
1,432
+74
+5% +$11.5K ﹤0.01% 2216
2018
Q4 		$219K Buy
1,358
+158
+13% +$31.4K ﹤0.01% 2022
2018
Q3 		$310K Buy
1,200
+117
+11% +$29.3K ﹤0.01% 1836
2018
Q2 		$247K Sell
1,083
-94
-8% -$17.8K ﹤0.01% 1818
2018
Q1 		$166K Buy
1,177
+242
+26% +$36.6K ﹤0.01% 2124
2017
Q4 		$122K Buy
935
+100
+12% +$12.7K ﹤0.01% 2417
2017
Q3 		$104K Sell
835
-1,884
-69% -$192K ﹤0.01% 2364
2017
Q2 		$234K Sell
2,719
-13,841
-84% -$1.21M ﹤0.01% 1667
2017
Q1 		$1.49M Sell
16,560
-310
-2% -$34.6K 0.03% 548
2016
Q4 		$1.84M Buy
16,870
+1,563
+10% +$171K 0.04% 452
2016
Q3 		$1.96M Buy
15,307
+215
+1% +$22.3K 0.05% 409
2016
Q2 		$1.37M Buy
+15,092
New +$1.31M 0.04% 493

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Advisor Group's CTSO Position: Q4 2019 in Review

Advisor Group reduced its Cytosorbents Corp (CTSO) stake by 3.6% in Q4 2019, selling an estimated $5.24K and leaving 1,584 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #2783.

Advisor Group first reported a position in CTSO in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.96M in Q3 2016. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Advisor Group held 1,584 shares of Cytosorbents Corp worth $122K as of Q4 2019.
  • Advisor Group sold 60 Cytosorbents Corp shares in Q4 2019, an estimated $5.24K.
  • Cytosorbents Corp made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2783 holding.
  • Advisor Group first reported a position in Cytosorbents Corp in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Cytosorbents Corp position peaked at $1.96M in Q3 2016.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.